Crossmark

Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira – 2022. Part I

Crossref DOI link: https://doi.org/10.1016/j.htct.2022.06.003

Published Print: 2022-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Maiolino, Angelo http://orcid.org/0000-0003-0140-9548
Crusoé, Edvan de Queiroz

Martinez, Gracia Aparecida

Braga, Walter Moisés Tobias

de Farias, Danielle Leão Cordeiro

Bittencourt, Rosane Isabel

Neto, Jorge Vaz Pinto

Ribeiro, Glaciano Nogueira

Bernardo, Wanderley Marques

Tristão, Luca

Magalhaes, Roberto J.P.

Hungria, Vânia Tietsche de Moraes
License Information

Text and Data Mining valid from 2022-07-01

Text and Data Mining valid from 2022-07-01

Version of Record valid from 2022-07-08
More Information

This article is maintained by: Elsevier

Article Title: Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira – 2022. Part I

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2022.06.003

Content Type: article

Copyright: © 2022 Published by Elsevier España, S.L.U. on behalf of Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular.

Document is current

Any future updates will be listed below